Rapid Urease Test and Faecal Antigen Detection for Rapid Diagnosis of <i>Helicobacter pylori</i> Infection in Dyspepsia
- 1 Tropical Medicine and Gastroenterology Department, Qena Faculty of Medicine, South Valley University, Qena, Egypt
- 2 Department of Clinical Pathology, Qena Faculty of Medicine, South Valley University, Qena, Egypt
- 3 Department of Pathology, Qena Faculty of Medicine, South Valley University, Qena, Egypt
Abstract
Background: Helicobacter pylori (H. pylori) is considered as one of the most prevalent gastric infections which cause chronic gastritis and predispose to cancer stomach. So, diagnosis and eradication should be rapid to decrease the risk of gastric cancer. Aim of the study: To evaluate the role of rapid urease test (RUT) and faecal antigen test (FAT) added to serological test for rapid diagnosis of active H. pylori infection. Patients and methods: 270 patients with dyspepsia and positive serology for H. pylori infection were included. Two antral and two corporal gastric biopsies were taken for RUT and Histopathological examination. Fresh stool samples were obtained from all patients for FAT. Results: The mean age of the studied patients was 45 ± 25. H. pylori infection was found in 256 (94.8%) of the included patients: 236 (92.18%) with positive all tests, 5 (1.95%) with positive both RUT and FAT, 8 (3.12%) with positive both histology and RUT and 7 (2.73%) with positive histology and FAT. The sensitivity, specificity and positive predictive values for RUT were as follows: 97.27%, 85.71% and 99.20% respectively and 96.88%, 85.71% and 99.20% respectively for FAT. Conclusions: RUT or FAT in patients with positive serological test could be used for rapid diagnosis of active H. pylori infection with good sensitivity and specificity without waiting for the results of histology or culture.
- Taylor, D.N. and Blaser, M.J. (1991) The Epidemiology of Helicobacter pylori Infection. Epidemiologic Reviews, 13, 42-59.
- Zhang, L., Blot, W.J., You, W.C., Chang, Y.S., Kneller, R.W., Jin, M.L., et al. (1996) Helicobacter pylori Antibodies in Relation to Precancerous Gastric Lesions in a High-Risk Chinese Population. Cancer Epidemiology, Biomarkers & Prevention, 5, 627-630.
- Malfertheiner, P., Chan, F.K. and McColl, K.E. (2009) Peptic Ulcer Disease. Lancet, 374, 1449-1461. http://dx.doi.org/10.1016/S0140-6736(09)60938-7
- Malfertheiner, P., Mégraud, F., O’Morain, C.A., Atherton, J., Axon, A.T.R., Bazzoli, F., et al. (2012) Management of Helicobacter pylori Infection—The Maastricht IV Florence Consensus Report. Gut, 61, 646-664. http://dx.doi.org/10.1136/gutjnl-2012-302084
- Shiotani, A., Cen, P. and Graham, D.Y. (2013) Eradication of Gastric Cancer Is Now Both Possible and Practical. Seminars in Cancer Biology, 23, 492-501. http://dx.doi.org/10.1016/j.semcancer.2013.07.004
- Gisbert, J.P. (2000) Revisión crítica de los métodos diagnósticos de infección por Helicobacter pylori. Gastroenterología y Hepatología, 23, 135-143.
- De Boer, W.A., De Laat, L. and Megraud, F. (2000) Diagnosis of Helicobacter pylori Infection. Current Opinion in Gastroenterology, 16, S5-S10.
- Working Party of the European Helicobacter pylori Study Group (1997) Technical Annex: Tests Used to Assess Helicobacter pylori Infection. Gut, 41, S10-8.
- Quan, C. and Talley, N.J. (2002) Management of Peptic Ulcer Disease Not Related to Helicobacter pylori or NSAIDs. The American Journal of Gastroenterology, 97, 2950-2961. http://dx.doi.org/10.1111/j.1572-0241.2002.07068.x
- Craanen, M.E., Dekker, W., Blok, P., Ferwerda, J. and Tytgat, G.N. (1992) Intestinal Metaplasia and Helicobacter pylori: An Endoscopic Bioptic Study of the Gastric Antrum. Gut, 33, 16-20. http://dx.doi.org/10.1136/gut.33.1.16
- National Institute of Health Consensus Conference (1994) Helicobacter pylori in Peptic Ulcer Disease. JAMA, 272, 65-69.
- Asaka, M., Kato, M., Takahashi, S., Fukuda, Y., Sugiyama, T., Ota, H., et al. (2010) Guidelines for the Management of Helicobacter pylori Infection in Japan: 2009 Revised Edition. Helicobacter, 15, 1-20. http://dx.doi.org/10.1111/j.1523-5378.2009.00738.x
- Dinis-Ribeiro, M., Areia, M., de Vries, A.C., Marcos-Pinto, R., Monteiro-Soares, M., O’Connor, A., et al. (2012) Management of Precancerous Conditions and Lesions in the Stomach (MAPS): Guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP) and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy, 44, 74-94. http://dx.doi.org/10.1055/s-0031-1291491